Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients

Coronavirus disease 2019 (COVID-19) caused a progress in research to find a solution to this pandemic. Also, various advances in pharmacotherapy against COVID-19 have emerged. Regarding antiviral therapy, casirivimab and imdevimab are antibodies combination against COVID-19. Standard antiviral thera...

全面介绍

书目详细资料
Main Authors: Hegazy Sahar K., Tharwat Samar, Hassan Ahmed H.
格式: 文件
语言:English
出版: De Gruyter 2023-08-01
丛编:Open Medicine
主题:
在线阅读:https://doi.org/10.1515/med-2023-0768